NATHBIOGEN Q4 FY26 Guidance vs Delivery (NATHBIOGEN Management Mirror)

Did NATHBIOGEN's management deliver what it guided? Guidance vs actual performance and tone changes across recent earnings calls, as of the Q4 FY26 (Mar-2026 Qtr) concall.

  • NATHBIOGEN Financials
  • NATHBIOGEN Shareholding Pattern
  • NATHBIOGEN Earnings Documents
  • NATHBIOGEN Announcements
  • NATHBIOGEN Corporate Actions
  • NATHBIOGEN Bulk, Block & Insider Deals
  • NATHBIOGEN Delivery Data
  • NATHBIOGEN Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Nath Bio-Genes (India) Ltd (NATHBIOGEN) Q4FY26 Management Mirror - Mar-2026 Qtr

Revenue & Top-Line Growth

Management continues to guide for 15% to 20% revenue growth for the upcoming fiscal year as of the Mar'26 Qtr, consistent with the outlook introduced in the Sep'25 Qtr and the baseline 15% target set in the Mar'25 Qtr, while maintaining the near-term milestone of crossing INR 500 crores in top-line sales. [Status: Reaffirmed]

4 more themes on the ELITE plan.

  • NATHBIOGEN Q4FY26 Concall Summary
  • NATHBIOGEN Q4FY26 Concall Transcript
  • NATHBIOGEN Q2FY26 Management Mirror (Sep-2025 Qtr)